Drugs / Engerix TM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00289744 | Feb 2004 → Apr 2009 | hepatitis A virus infection, hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Engerix TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00289744 ↗ |
| Modality | Vaccine | “additional vaccine dose” NCT00289744 ↗ |